Drdo
-
Agni-Prime: Nuclear capable missile successfully test-fired off Odisha coast
India | Jun 28, 2021, 12:31 PM ISTAgni-Prime is a short-range ballistic missile. It is a new generation advanced variant of the Agni class of missiles. It is a canisterised missile with a range capability between 1,000 and 2,000 kms.
-
2-DG: Dr Reddy's announces commercial launch of Covid-19 drug; MRP fixed at Rs 990/sachet
India | Jun 28, 2021, 11:47 AM IST2-deoxy-D-glucose (2DG) is an oral anti-viral drug for Covid-19 patients. The drug has generated a lot of curiosity after it was launched on May 17 by the Ministry of Defence.
-
DRDO successfully test fires enhanced version of Pinaka rocket | Video
India | Jun 25, 2021, 07:59 PM ISTAs many as twenty-five rockets were launched in quick succession and the test met complete mission objectives, defence sources said.
-
PM Cares funded 500-bed DRDO Covid hospital in Srinagar, admitting patients now
India | Jun 12, 2021, 12:55 PM ISTA 500-bed COVID hospital set up using funds from PMCARES Fund has started admitting patients now.
-
DRDO invites EoI to transfer technology of 2-DG drug for bulk production
India | Jun 09, 2021, 02:35 PM IST2-DG was developed by the Institute of Nuclear Medicine and Allied Sciences (INMAS), a lab of DRDO, in collaboration with Dr Reddy's Laboratories.
-
Jammu: DRDO sets up 500-bedded COVID makeshift hospital at Bhagwati Nagar under PM CARES Fund
India | Jun 04, 2021, 01:58 PM ISTOf the total 500 beds at Bhagwati Nagar Centre, 125 would be Intensive Care Unit (ICU) beds, while others would be a set of Covid beds with 24 hours oxygen facility.
-
DRDO opens 500-bed Covid Care Centre in Uttarakhand's Haldwani
India | Jun 02, 2021, 05:01 PM ISTThe Covid Care Centre has been dedicated and named after General Bipin Chandra Joshi, PVSM, AVSM, ADC who belonged to state of Uttarakhand and was the 17th Chief of Indian Army.
-
2-DG: How and when to use DRDO's anti-Covid drug? Guidelines
India | Jun 01, 2021, 01:37 PM IST2-DG is an oral anti-viral drug for Covid-19 patients. It has been developed by the DRDO in collaboration with Dr Reddy's Laboratories. It reduces dependence on supplemental oxygen.
-
DRDO's 500-bed Covid hospital inaugurated in Jammu
India | May 29, 2021, 06:41 PM ISTOf the total 500 beds here at Bhagwati Nagar Centre, 125 would be Intensive Care Unit beds, while others would be a set of Covid beds with 24 hours oxygen facility.
-
2-DG: DRDO's Covid-19 drug to be available for Rs 990, commercial launch in mid-June
India | May 28, 2021, 04:54 PM ISTThe price of DRDO’s 2DG anti-COVID 19 drug has been fixed at Rs 990 per sachet by Dr Reddy’s lab.
-
DRDO develops Covid-19 antibody detection kit 'DIPCOVAN'
India | May 21, 2021, 05:54 PM ISTThe DIPCOVAN kit can detect both spike as well as nucleocapsid (S&N) proteins of SARS-CoV-2 virus with a high sensitivity of 97% and specificity of 99%.
-
DRDO's 2G drug a 'repurposed' medicine, not new: ICMR
India | May 20, 2021, 05:53 PM ISTIndia's first indigenous anti-COVID drug 2-DG is a "repurposed" medicine, the Indian Council of Medical Research said on Thursday. According to ICMR DG Dr. Balram Bhargava, the drug was earlier used for cancer treatment.
-
Dr Reddy's releases important information regarding anti-Covid drug 2DG
India | May 19, 2021, 10:34 PM ISTDr Reddy's on Wednesday released important information regarding drug 2-deoxy-D-glucose (2DG), developed by INMAS, a DRDO lab in collaboration with Dr. Reddy’s Laboratories.
-
Haryana to purchase DRDO's anti-COVID drug for treating coronavirus patients: Anil Vij
India | May 18, 2021, 08:05 AM ISTHaryana on Monday reported 114 COVID deaths and 7,488 fresh cases, taking the state’s fatality count to 6,799 and the total infection number to 7,01,915, according to a Health Department bulletin.
-
COVID India Updates: Bleeding, clotting events following vaccination 'minuscule' in India
Health | May 17, 2021, 11:22 PM ISTThe first batch of 2-deoxy-D-glucose (2-DG) drug developed by the Defence Research and Development Organisation (DRDO) for treatment of Covid-19 was released by Defence Minister Rajnath Singh on Monday. The medicine is being touted as a game-changer in the fight against COVID.
-
Rajnath Singh to release first batch of DRDO's drug 2-DG for Covid treatment
News | May 17, 2021, 11:20 AM ISTThe first batch of drug 2-deoxy-D-glucose drug to treat Covid-19 patients will be launched today. The drug has been developed by the Defence Research and Development Organisation (DRDO) in collaboration with Dr Reddy's Laboratories (DRL).
-
DRDO's 2-DG drug for treating Covid patients launched; to reduce dependence on oxygen
India | May 17, 2021, 11:51 AM ISTThe 2-DG (2-deoxy-D-glucose) is an anti-COVID-19 therapeutic application of the drug. It has been developed by DRDO and Dr Reddy's Laboratories.
-
DRDO imports zeolite to make oxygen for COVID-hit
India | May 16, 2021, 11:42 PM IST"The two aircraft carrying zeolite from Rome arrived as the first consignment of the key component," a DRDO official told IANS.
-
DRDO's anti-COVID drug 2-DG's first batch to be released today
India | May 17, 2021, 12:02 AM ISTThe first batch of anti-COVID drug 2-DG, developed by the DRDO, will be released on Monday (May 17) by Defence Minister Rajnath Singh and Health Minister Harsh Vardhan, officials said.
-
First batch of 10,000 doses of DRDO's 2DG Covid drug to launch next week
India | May 14, 2021, 11:48 PM ISTAt a time when country battles with the second wave of coronavirus, the first batch of 10,000 doses of 2DG medicine for curing COVID-19 patients would be launched early next week and will be given to patients, DRDO officials informed on Friday.